| | | | | |
PLMK Plum Acquisition Corp. IV Class A Ordinary Shares | €9,1483 | +0,00% | €221,46M | €19,94K | |
DMAA Drugs Made In America Acquisition Corp. Ordinary Shares | €9,1182 | +0,00% | €221,36M | €87,65 | |
ERC Allspring Multi-Sector Income Fund | €7,7999 | +0,07% | €221,32M | €23,67K | |
GLO Clough Global Opportunities Fund | €5,2123 | +0,50% | €221,25M | €38,45K | |
NTWO Newbury Street II Acquisition Corp Class A Ordinary Shares | €9,1664 | +0,24% | €221,14M | €106,56 | |
TRGS TRG Latin America Acquisitions Corp. Class A Ordinary Shares | €8,4900 | -0,01% | €220,66M | €14,02K | |
CPZ Calamos Long/Short Equity & Dynamic Income Trust Common Stock | €11,0338 | -0,09% | €220,17M | €25,84K | |
| €3,4797 | +4,36% | €219,91M | €44,78K | |
ALXO ALX Oncology Holdings Inc. Common Stock | €1,4911 | +3,89% | €219,72M | €138,45K | |
PNNT Pennant Investment Corp | €3,4591 | +3,47% | €219,41M | €187,38K | |
VNME Vendome Acquisition Corporation I Class A Ordinary Shares | €8,7702 | -0,05% | €219,14M | €199,38 | |
NUW Nuveen AMT-Free Municipal Value Fund | €12,0703 | +0,61% | €219,06M | €21,41K | |
| €33,8182 | +3,23% | €219,06M | €2,31K | |
DSP Viant Technology Inc. Class A Common Stock | €10,8027 | +3,88% | €218,86M | €41,67K | |
| €25,0008 | +1,86% | €218,76M | €12,75K | |
